Cointime

ADM Diagnostics

company

About

This company is provides cutting edge analysis of brain images to enable disease diagnosis.

  • 1 - 10

Highlights

Total Funding Amount
$0.93M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$0.93M
Industries
Health Care,Health Diagnostics
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

ADMdx specializes in brain image analysis to enable diagnosis, prognosis, and drug effect detection for Alzheimer's disease and various other forms of dementia. We provide pharmaceutical companies with powerful information to improve clinical trial success. ADMdx provides image data analysis and full CNS imaging study services with structural MRI, amyloid PET, tau PET, FDG PET, ASL, fMRI BOLD, and DTI. We are developing diagnostic products to enable early, accurate disease detection supporting optimal patient care.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$0.93M
ADM Diagnostics has raised a total of $0.93M in funding over 2 rounds. Their latest funding was raised on Apr 9, 2013 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 9, 2013 Grant $0.93M 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
ADM Diagnostics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Cointime
Содержание
компания